Chalcones with potential antibacterial and antibiofilm activities against periodontopathogenic bacteria

Objectives: Periodontitis is a pathology resulting from complex interaction of microorganisms in the dental biofilm with the host's immune system. Increased use of antibiotics associated with their inappropriate use has increased resistance levels in anaerobic bacteria. Therefore, identifying n...

Descripción completa

Detalles Bibliográficos
Autores: Satokata, Alessandra Akemi Cury, Souza, Jonathan Henrique, Silva, Luana Luiza Oliveira, Santiago, Mariana Brentini, Ramos, Salvador Boccaletti, Assis, Leticia Ribeiro de [UNESP], Theodoro, Reinaldo dos Santos [UNESP], Oliveira, Lígia Rodrigues e [UNESP], Regasini, Luis Octavio [UNESP], Martins, Carlos Henrique Gomes
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2022
País:Brasil
Institución:Universidade Estadual Paulista (UNESP)
Repositorio:Repositório Institucional da UNESP
Idioma:inglés
OAI Identifier:oai:repositorio.unesp.br:11449/240154
Acceso en línea:http://dx.doi.org/10.1016/j.anaerobe.2022.102588
http://hdl.handle.net/11449/240154
Access Level:acceso abierto
Palabra clave:Anaerobic bacteria
Antibacterial activity
Antibiofilm activity
Chalcone
Periodontitis
Descripción
Sumario:Objectives: Periodontitis is a pathology resulting from complex interaction of microorganisms in the dental biofilm with the host's immune system. Increased use of antibiotics associated with their inappropriate use has increased resistance levels in anaerobic bacteria. Therefore, identifying new antimicrobial compounds, such as chalcones, is urgent. This study evaluates the antibacterial activity and the antibiofilm activity of 15 chalcones against the periodontopathogenic bacteria Prevotella nigrescens (ATCC 33563), P. oralis (ATCC 33269), Peptostreptococcus anaerobius (ATCC 27337), Actinomyces viscosus (ATCC 43146), Porphyromonas asaccharolytica (ATCC 25260), and Fusobacterium nucleatum (ATCC 25586). Methods: The compounds were evaluated by minimum inhibitory concentration (MIC) and minimum biofilm inhibitory concentration (MBIC) tests. Results: Compounds 1–6 showed good antibacterial and antibiofilm activities against most of the evaluated bacteria: MIC was lower than or equal to 6.25 μg/mL, biofilm biomass was reduced by 95%, and the compounds at concentrations between 0.78 and 100 μg/mL totally inhibited cell viability. Among the tested chalcones, 3 stood out: it was effective against all the bacteria, as revealed by the MIC and MBIC results. Conclusions: Our results have consolidated a base for the development of new studies on the effects of the tested chalcones as agents to combat and to prevent periodontitis.